Nicholas Leonardi, DO
Plastic and Reconstructive Surgery · Germantown, TNNPI 1104072651
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $3,396 of the $4,158 with a category attached, or 81.7%. 25 manufacturers reported payments, led by AbbVie at 27.1% of the total.
Across 132 payments — averaging $31.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Stryker$826
- Smith+Nephew$594
- Mentor Worldwide LLC$514
- Organogenesis Inc.$235
- Integra Lifesciences Corporation$170
- plus $691 from 19 others
What the payments were for
- Travel & lodging$76218%
- Food & beverage$3,39682%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 41 | $1,128 |
| Stryker | 4 | $826 |
| Smith+Nephew | 13 | $594 |
| Mentor Worldwide LLC | 24 | $514 |
| Organogenesis Inc. | 6 | $235 |
| Integra Lifesciences Corporation | 6 | $170 |
| Sientra, Inc. | 7 | $127 |
| Acera Surgical, Inc. | 6 | $106 |
| KCI USA, Inc. | 4 | $70 |
| Merck | 3 | $48 |
| Innovation Technologies Inc | 1 | $42 |
| Johnson & Johnson | 1 | $37 |
| Motiva USA, LLC | 2 | $32 |
| TELA Bio, Inc. | 2 | $30 |
| Daiichi Sankyo Inc. | 2 | $28 |
| Kerecis Limited | 1 | $27 |
| Somavac Medical Solutions, Inc. | 1 | $27 |
| Surgical Specialties Corporation (US), Inc. (dba Corza Medical) | 1 | $19 |
| Polynovo North America LLC | 1 | $18 |
| Revance Therapeutics, Inc. | 1 | $15 |
| Reprise Biomedical, Inc. | 1 | $15 |
| Zimmer Biomet | 1 | $14 |
| Acell, Inc. | 1 | $13 |
| Avanos Medical | 1 | $13 |
| Medela LLC | 1 | $10 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,158 in reported general payments places this provider in the 65th percentile of 77 plastic and reconstructive surgery providers in Tennessee.
See all plastic and reconstructive surgery providers in Tennessee →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 66 | $432 |
| Minocycline Hcl | 32 | $377 |
| Cyclobenzaprine Hcl | 21 | $95 |
Paid to pharmacies, not to this prescriber.
Other plastic and reconstructive surgery in Germantown
- Sarah HammondGermantown$9K
- William HickersonMemphis$833K
- Daniel HatefNashville$673K
- Mark BrzezienskiChattanooga$32K
- Earl LettMount Juliet$29K
- Robert WallaceMemphis$21K
- Lois WagstromNashville$19K
- Jordi Puente EspelNashville$16K
- David LoKnoxville$13K
- Roberto LachicaMemphis$13K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.